Granules India Completes Acquisition of Senn Chemicals
ECONOMY & POLICY

Granules India Completes Acquisition of Senn Chemicals

Granules India Ltd. has officially closed the acquisition of Senn Chemicals AG, a Switzerland-based CDMO specialising in peptide development and manufacturing. This strategic move marks Granules’ entry into the peptide therapeutics segment and contract development and manufacturing (CDMO) services, bolstering its innovation-led growth strategy. 

The acquisition, executed through Granules’ wholly owned subsidiary Granules Peptides Pvt. Ltd., involves a 100% equity stake purchase from the founding Senn family. 

Headquartered in Dielsdorf, Switzerland, Senn Chemicals brings over six decades of expertise in Liquid-Phase and Solid-Phase Peptide Synthesis (LPPS & SPPS), serving pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets. 

Dr. Krishna Prasad Chigurupati, Chairman and MD of Granules India, highlighted the deal as a “pivotal step” in the company’s evolution into a science- and innovation-led enterprise. He emphasised the synergy between Senn’s peptide specialisation and Granules’ global manufacturing capabilities to drive high-quality, next-gen treatments in areas such as GLP-1 receptor agonists, anti-diabetic, and anti-obesity therapies. 

The acquisition also marks Granules’ formal entry into the CDMO sector, enhancing its global footprint with access to regulated markets, top-tier European scientific talent, and advanced R&D capabilities. Joint development initiatives in peptide APIs are already underway, with an expanded pipeline in the works. 

Advisors on the deal included Stifel Nicolaus India (financial), Loyens & Loeff (legal), Deloitte (financial and tax diligence), and Kroll (valuation). 

This acquisition strengthens Granules’ innovation capabilities and positions it as a key player in the rapidly growing complex therapeutics and CDMO markets. 


(BSE)     

Granules India Ltd. has officially closed the acquisition of Senn Chemicals AG, a Switzerland-based CDMO specialising in peptide development and manufacturing. This strategic move marks Granules’ entry into the peptide therapeutics segment and contract development and manufacturing (CDMO) services, bolstering its innovation-led growth strategy. The acquisition, executed through Granules’ wholly owned subsidiary Granules Peptides Pvt. Ltd., involves a 100% equity stake purchase from the founding Senn family. Headquartered in Dielsdorf, Switzerland, Senn Chemicals brings over six decades of expertise in Liquid-Phase and Solid-Phase Peptide Synthesis (LPPS & SPPS), serving pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets. Dr. Krishna Prasad Chigurupati, Chairman and MD of Granules India, highlighted the deal as a “pivotal step” in the company’s evolution into a science- and innovation-led enterprise. He emphasised the synergy between Senn’s peptide specialisation and Granules’ global manufacturing capabilities to drive high-quality, next-gen treatments in areas such as GLP-1 receptor agonists, anti-diabetic, and anti-obesity therapies. The acquisition also marks Granules’ formal entry into the CDMO sector, enhancing its global footprint with access to regulated markets, top-tier European scientific talent, and advanced R&D capabilities. Joint development initiatives in peptide APIs are already underway, with an expanded pipeline in the works. Advisors on the deal included Stifel Nicolaus India (financial), Loyens & Loeff (legal), Deloitte (financial and tax diligence), and Kroll (valuation). This acquisition strengthens Granules’ innovation capabilities and positions it as a key player in the rapidly growing complex therapeutics and CDMO markets. (BSE)     

Next Story
Infrastructure Transport

Railways Completes Odisha’s Longest Tunnel on Khurda–Balangir Line

Indian Railways has completed the construction of Tunnel T-4, the longest tunnel on the Khurda Road–Balangir railway line, marking a significant milestone in Odisha’s railway infrastructure. The 4,185-metre tunnel connects Adenigarh and Charichhak in Boudh district and is now the longest in the state. Railway officials confirmed the successful breakthrough of the tunnel on 16 April, an event referred to as "daylighting", indicating full excavation from one end to the other. The Khurda Road–Balangir rail line spans 301 kilometres, of which 226 kilometres have been completed. Existing op..

Next Story
Infrastructure Urban

Centre May Target Rs Two Trillion Asset Monetisation in FY 2025–26

The Central government is likely to set an asset monetisation target of Rs 1.9 to two trillion for the financial year 2025–26 under Phase Two of the National Monetisation Pipeline (NMP), with a strong emphasis on sectors such as roads, power, railways, and coal and mines. According to officials, development of vacant public land will also emerge as a key pillar of asset recycling in this phase. NMP Phase Two aims to build on the success of NMP 1.0 (FY 2022–25), which achieved Rs 5.65 trillion of the Rs six trillion target. Monetisation formats will include upfront lease revenues, reven..

Next Story
Infrastructure Transport

Joint DPR Proposed for Road And Rail Projects Through ShiradiGhat

Dakshina Kannada MP Captain Brijesh Chowta has called on the Karnataka Chief Secretary to initiate joint planning between the National Highways Authority of India and the Ministry of Railways for road and rail infrastructure through the ecologically sensitive ShiradiGhat corridor. During a meeting with Chief Secretary Dr Shalini Rajneesh, Chowta emphasised the need for a coordinated Detailed Project Report to reduce environmental impact, streamline inter-departmental approvals, and avoid duplication of efforts. Currently, the two agencies are independently preparing DPRs for National Highway..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?